Tuesday
SESSION 4: MORE ABOUT NEW DEVELOPMENTS IN THE TREATMENT OF TBADs AND RELATED ENTITIES
Moderators:Christoph A. Nienaber, MD, PhD / Frank J. Veith, MD  
SESSION 4 SCHEDULE
10:10 AM - 10:15 AM Natural History Of Penetrating Ulcers In The Thoracic Aorta: When Should They Be Treated Conservatively And When By TEVAR
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
10:16 AM - 10:21 AM Natural History Of Intramural Hematomas In The Thoracic Aorta: When Should They Be Treated Conservatively And When By TEVAR
  Presenter(s):Santi Trimarchi, MD, PhD  
  View Slides in PDF      
10:22 AM - 10:27 AM How To Follow TBAD Patients On Medical Treatment And After TEVAR: What Secondary Interventions May Be Required And When
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
10:28 AM - 10:33 AM Detecting False Lumen Thrombosis In TBAD Patients: It Is Not So Easy: What Technique Is Most Reliable
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Slides in PDF      
10:34 AM - 10:39 AM DEBATE: When Performing TEVAR For Acute Uncomplicated TBAD, The Procedure Should Be Delayed 2-12 Weeks (~6 Weeks) After The Event To Decrease Chances Of Retrograde Dissection
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM DEBATE: It Is Safe To Perform TEVAR For Uncomplicated TBAD Within <2 Weeks Of The Acute Event If Certain Precautions Are Taken
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
10:46 AM - 10:51 AM 4-Year Results With Bolton Relay Graft For TEVAR And New Modifications Of The Platform Including Proximal And Distal Scallops And Ways To Prevent Proximal Migration
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
10:52 AM - 10:57 AM Why Patients With TBAD Can Benefit From Dissection Flap Disruption (Septotomy): How It Can Be Done Safely And A Device To Do It
  Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD  
  View Slides in PDF      
10:58 AM - 11:04 AM Panel Discussion
Moderator(s): Hazim J. Safi, MD / Roberto Chiesa, MD  
11:04 AM - 11:09 AM There Is No Such Thing As A Chronic TBAD: Why Our Thinking And Nomenclature Should Change
  Presenter(s):Firas F. Mussa, MD  
  View Slides in PDF      
11:10 AM - 11:15 AM Staged Hybrid Procedure (Proximal TEVAR And Open Distal TAAA Repair) Is A Better Way To Treat TBAD With Extensive TAAA: Technique, Advantages And Limitations
  Presenter(s):Gilbert R. Upchurch, MD  
  View Slides in PDF      
11:16 AM - 11:21 AM False Lumen Outflow Resistance As A Predictor Of The Need For Late Reintervention With Uncomplicated TBAD: How To Measure And What To Do With This Measurement
  Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD  
  View Slides in PDF      
11:22 AM - 11:27 AM Expanding Midterm Experience With Fenestrated And Branched EVAR (F/BEVAR) For TAAAs From Chronic TBADs: Advantages And Limitations
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Piotr M. Kasprzak, MD  
  View Slides in PDF      
11:28 AM - 11:33 AM TEVAR Endografts For TBADs Can Cause New Distal Entry Tears: How To Detect And Treat Them
  Presenter(s):Chun Che Shih, MD, PhD  
  View Slides in PDF      
11:34 AM - 11:39 AM Application Of Occlusive Devices In The Endovascular Treatment Of Difficult Aortic Lesions (Dissections And False Aneurysms) Unsuitable For Endograft Repair
  Presenter(s):Guangqi Chang, MD  
  View Slides in PDF      
11:40 AM - 11:45 AM Peripheral Vascular Complications Of TEVAR And TAVI: How To Prevent And Treat Them
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
11:46 AM - 11:51 AM What Proportion Of Strokes With TEVAR Are Due To Air Emboli And Not Particulate Emboli: CO2 Flushing Of Devices Can Prevent Air Embolic Strokes
  Presenter(s):Tilo Koelbel, MD, PhD / Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 4
previous next